A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
PHASE3
This 2 arm study will compare the efficacy and safety of sequential treatme...
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
NA
This ALCHEMIST trial studies genetic testing in screening patients with sta...
A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer
PHASE2
This phase 2 study is a multicenter, randomized, double-blind, placebo-cont...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.